HIV Clinical Trials Market Poised for Accelerated Growth, Forecasts Reveal Steady Expansion with Notable CAGR Through 2030
January 10, 2024 20:48 ET
|
Research and Markets
Dublin, Jan. 10, 2024 (GLOBE NEWSWIRE) -- The "Global HIV Clinical Trials Market by Phase (Phase I, Phase II, Phase III), Study Design (Expanded Access Studies, Interventional Studies, Observational...
Outlook on the HIV Clinical Trials Global Market to 2030 - Rising Drug Approvals and New Product Launches is Driving Growth
August 29, 2022 06:33 ET
|
Research and Markets
Dublin, Aug. 29, 2022 (GLOBE NEWSWIRE) -- The "Global HIV Clinical Trials Market Size, Share & Trends Analysis Report by Phase (Phase I, Phase II, Phase III, Phase IV), by Study Design...
GeoVax Announces Clinical Trial Initiation of Novel Combination Therapy Utilizing MVA62B to Induce Remission in HIV-Positive Patients
August 24, 2020 09:00 ET
|
GeoVax, Inc.
ATLANTA, GA, Aug. 24, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – GeoVax Labs, Inc. (OTCQB: GOVX), a biotechnology company developing human immunotherapies and vaccines against infectious diseases...
GeoVax Provides Update on HIV Clinical Trials Program
November 28, 2018 09:00 ET
|
GeoVax, Inc.
Innovative Combination Vaccine Advancing in Clinical Trials ATLANTA, GA, Nov. 28, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- GeoVax Labs, Inc. (OTCQB: GOVX), a biotechnology company...